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Abstract
The Effects of Anti-Depressant Advertising on Perception of Depression in College Students at
Marshall University
Deirdre Robertson
This exploratory study was designed to determine the effects, if any, of direct-toconsumer advertising of anti-depressants on Marshall University students’ perceptions of
depression and anti-depressant medication. For the purposes of the study, two versions of an
advertisement were created: one including three false statements regarding depression and antidepressants, and one without false statements. A fifteen-question survey was also created as a
baseline to measure whether the advertisement condition had any direct effects on the
participants’ perceptions of depression and anti-depression and to provide comparison for the
participants’ reactions. All three groups took the survey. There were ninety participants in the
study, split into three groups of thirty, including a group that viewed the commercial with false
statements, a group that viewed the commercial without false statements, and a control group
that did not view any advertisement.
Analysis of the results revealed that there was not a significant link between the
information presented in the advertisement conditions and participants’ perceptions of depression
and anti-depressants. The participants’ responses on the survey did not appear to be influenced
by the false information in the advertisement. Results did not support the expectation that the
advertising condition would significantly alter the perceptions of college students regarding
depression and its treatment.
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Chapter One: Introduction
More than 19 million American adults suffer from depressive disorders, according to the
American Psychological Association (APA) in 2007. At any given time, depression generally
affects 5% of the population (Goldney, Fisher, & Wilson, 2001). In fact, the disabilities
associated with Major Depressive Disorder (MDD) are surpassed only by those associated with
ischemic heart disease (Waraich, Goldner, Somers, & Hsu, 2004). When dealing with any such
prevalent disease, it is imperative to recognize symptoms, seek diagnosis, and receive
appropriate treatment. However, depression is not as easily recognizable as the flu or a cold, and
the general population is not well informed about its symptoms. Mental health literacy,
especially in terms of depression, is vital to controlling the prevalence of the disease (Waraich,
Goldner, Somers, & Hsu, 2004).
The increased prescription of anti-depressants has not necessarily been successful in
combating the elevating frequency of depression (de Jonghe, Hendriksen, van Aalst, Kool, Peen,
Van, van den Eijnden, & Dekker, 2004). There has been no success in finding biological
predictors in responses to anti-depressant treatment. What have been successful, however, are
investigations into psychological predictors for response; these findings have established that the
effectiveness of anti-depressant treatment can only be judged on a case-by-case basis and are
better determined by physicians with a psychiatric background (de Jonghe, et. al., 2004).
According to this study, the average physician is not qualified to create a psychiatric profile
detailed enough to determine whether or not anti-depressant treatment will be effective in most
patients; the increased prescription of anti-depressants based on direct-to-consumer advertising
supports this conclusion.

2
To understand the modern public conception of depression, one must look at modern
public information sources. Much of public knowledge comes from anti-depressant
commercials, magazine advertisements, and the Internet, not from accredited medical sources
(Goldney, Fisher, & Wilson, 2001). In 2000, the pharmaceutical industry spent 1.8 billion dollars
on direct-to-consumer-advertising (DTCA) of prescription drugs, most of which was spent on
television making it an important source of information for the general public (Polen, Khanfar, &
Clauson, 2009).
Advertising, and particularly television advertising, has long been recognized as a source
for individuals to learn and model behavior through social learning (Philips & Orton, 1983).
Albert Bandura‘s theory of Social Learning claims that individuals learn accepted social
behaviors and expectations through modeling or observing others and forming an idea of how
certain behaviors are performed; individuals then use this coded information to determine similar
actions in the future (Bandura, 1977). According to Bandura‘s theory, there are several levels of
observational learning, the first of which is achieved by first ―
organizing and rehearsing the
modeled behavior symbolically and then enacting it overtly (Bandura, 1986).‖ The theory also
suggests that individuals are likely to adopt the modeled behavior if it demonstrates an outcome
valued or desired by the individual, particularly if the model is similar to the observer and has
admired status. For effective modeling, Bandura claims that the following conditions must be
met: first, attention must be paid; taking in considerations of factors which increase or decrease
attentions such as distinctiveness, affective valence, prevalence, complexity, and functional
value. Secondly, the observer must retain the information presented, typically using symbolic
coding, mental images, cognitive organization, symbolic rehearsal, and motor rehearsal. Thirdly,
for successful modeling, the modeled behavior must be reproduced, including the use of physical
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capabilities and self-observation. Finally, the observer must be motivated or presented with a
good reason to imitate the modeled behavior. The use of traditional behaviorism promised or
imagined incentives, and vicarious models that reinforce the original intent of the model
(Bandura, 1986).
The use of Social Learning in advertising is pervasive. ―
The constant flow of advertising
images of gender, types of persons, social classes, and other groups influence our social learning
process‖ (Roy, 1998). According to the same article, advertising plays an important role in social
reinforcement by using modeled behaviors to cultivate certain opinions, attitudes, and behaviors;
advertising not only sells products and services by providing individuals with coded information,
but indirectly suggests ways in which to understand the world (Roy, 1998).
A recent study found that print advertising is generally more informative than television
advertising, and the researchers concluded that the DTC television advertisements were not
doing a thorough job of meeting the FDA‘s fair balance requirements, particularly when
presenting information about the risks of the advertised prescription drug (Macias, Pashupati, &
Lewis, 2007). The fair balance requirement for DTCA is flexible and prohibits only ads that
convey a deceptive impression of the risk and benefits from the overall presentation of
information, rather than those that fail to achieve a mechanistic balance between risk and benefit
information because they do not present such information with identical emphasis" (FDA, 2007).
Fair balance requirements do not mandate that all side-effect information or potential
risks must be included in the advertisement, but that they must be in balance with the benefits
presented. These benefits and risks must also be comparable to those presented in advertisements
for other prescription drugs. This allows the industry the means of self-regulating its use of risk
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information in DTCA, which may or may not satisfy the original requirements laid down by the
FDA (FTC, 2003).
It has been suggested that direct-to-consumer advertising has significantly increased
frequency of prescriptions of anti-depressant drugs in recent years (Hersey, 2004). ―
The
increasing visibility of direct-to-consumer antidepressant advertising coincides with growing
numbers of antidepressant treatments‖ (Apfel, 2003). Several studies have noted how patients
complaining of depressive symptoms are more likely to receive a diagnosis and subsequent
medication by mentioning a specific advertisement to their doctors (Ackman & Glied, 2002).
Healthcare consumers in recent years have taken a more active role in determining what they are
prescribed, making their education regarding prescriptions drugs more important than is being
addressed by DTCA (Macias, et.al, 2007). In fact, according to a study using a sixty-eight
question survey regarding participant attitudes toward DTCA, a large portion of the group
(58.6%) believed that DTCA encourages consumers to take a more active role in managing their
prescriptions, while 27.6% felt that DTCA caused more confusion regarding the benefits and
harms of prescription drugs on the market and believed that the costs of DTCA outweigh its
benefits (Polen, et.al, 2009). The major purpose of this research is to explore what role, if any,
DTCA plays in the public‘s perception of depression and anti-depressants, as well as how DTCA
affects the college-age population.
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Chapter 2: Review of Literature
There are many examples of DTCA influence on consumers in their interactions with
their physicians. A patient preparing for cataract surgery provided her nurse with a detailed list
of believed symptoms and preferred medications she wished prescriptions for upon discharge,
despite the fact that her physician was an opthamologist and was unqualified to prescribe
medications for high cholesterol, osteoporosis, and acid reflux. This example demonstrates that
DTCA may increase the likelihood of consumer self-diagnosis and complicate the balance
between physicians and patients (Salladay, 2007). In another example, a physician, Frey (2003),
describes a visit to his clinic by an eleven-year-old boy and his mother who demanded Lamisil,
based on an advertisement the boy had seen on television that showed fingernails that looked like
his own. When Frey prescribed a generic alternative considered to be just as effective, despite his
belief that the prescription was ultimately unnecessary, both the mother and the boy left
disappointed that their request for the brand-name medication had been denied (Frey, 2003).
Such examples demonstrate the influence that DTCA can have on consumer perceptions and
preferences for medications advertised most prevalently (Royne & Myers, 2008).
A study examining antidepressant advertisements analyzed the ―
messages‖ embedded in
both imagery and words commonly used in advertisements. The researchers used semiotics and
frame analysis to examine the advertisements by applying Manning‘s (1987) five points of
analysis. According to the article, Manning‘s model suggests a comprehensive means of viewing
semiotic methodology (Bell, Kravitz, & Wilkes, 2000). Manning argues that semiotics
constitutes a model that is ―
rooted in culture and seeks to identify the rules or principles that
guide signification, the process by which objects in the world communicate meaning‖ (Manning,
1987). The five points of analysis are used to analyze signs and what they symbolize and how
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they relate to one another, second, how they are articulated, third, how they function socially,
fourth, to what degree they are integrated, and finally, to determine what, if any, are the
mythological components to their construction. The researchers were able to find that most antidepressant advertisements are framed as a bio-chemical issue and are highly skewed toward
women. Consumers are presented with a simplistic construction of a complicated medical
condition that cannot be bound by gender or biological components but is frequently a response
to ―soc
ial and cultural circumstances,‖ which encourages consumers to follow the advice of
advertisements rather than that of their own doctors (Bell, et.al, 2000).
One study found that the number of people diagnosed with depression and prescribed
anti-depressants was significantly higher during periods when direct-to-consumer advertising
(DTCA) spending was highest (cumulatively over 18.5 million). Patients diagnosed during this
period were 32% more likely to begin medication (Donahue, Berndt, Rosenthal, Epstein, &
Frank, 2004). In another study, a twenty-one item survey was sent to 604 prescribing clinicians
asking details about their prescription rates and how they were affected by DTCA. Most of the
respondents (87%) reported that DTCA prompted their patients to request inappropriate
medications and more than one in five of the reporting clinicians stated they experienced
difficulty persuading said patients to accept more appropriate prescriptions (Fortuna, RossDegnan, Finkelstein, Fang, Campion, & Simon, 2008).
It is necessary to determine the extent advertising influences current views on depression
and current forms of medication and treatment if the communications and psychology
communities are to address the growing concerns regarding the relationship between increased
prescription of anti-depressants and prescription advertising (McKay, 2000). Medications like
anti-depressants for conditions with unclear diagnoses may be responsible for more potential

7
harm to consumers than other types of advertised medications. Depression is a more complicated
diagnosis with symptoms that aren‘t clear to someone who is not a trained professional; such
advertising is more likely to encourage unwitting consumers to seek treatment for a condition
from which they do not suffer (Royne & Myers, 2008).
Critics of DTCA claim that this form of advertising compromises the physician–
patient relationship and confuses patients by presenting promotional messages as educational
(Wolfe 2002). Proponents of this view also claim that DTCA increases consumer demand for
brands and more expensive medications rather than providing appropriate information needed to
make better health-care decisions (Mintzes 2002). Appel (2002) examined public perception of
DTCA, particularly regarding the anti-depressant Prozac, and found that patients with depression
may seek treatment because of Prozac advertisements. However, influence from the advertising
has in some cases prompted patients to choose brand-name anti-depressants over equally
effective generic drugs in the same classes that might be more appropriate. Experts also claim
that the medications presented in DTCA often give the appearance of being ‗‗new and
improved‘‘ over alternative treatments, while in many cases older and frequently less expensive
drugs may actually be the best treatment.
An‘s study (2008) conducted in the Midwest, found there was an effect on the perceived
prevalence of depression in subjects presented with anti-depressant DTCA. The study showed
that those with a higher recall for the advertising were more likely to estimate the prevalence of
depression as being higher than those who had lower recall. The study showed that when the
subjects were reminded where their information was taken from, its veracity was doubted and the
significant association was eliminated. The researchers concluded that while people are more
likely to remember the information presented in anti-depressant DTCA and make use of the
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information, they will in most cases doubt its validity when reminded of its source. However, in
normal situations when the source is not highlighted, the subjects were more likely to adhere to
information presented in the DTCA, which argues for more cautious and thorough advertising.
Several studies dealing with the increased rate of prescription due to the claim of
increased direct-to-consumer advertising have found that most patients prescribed antidepressants by their regular physicians do not seek outside psychological treatment. According
to a recent study, evidence suggests that general practitioners often find making decisions and
diagnoses for depression problematic, but appropriate prescriptions are also difficult. It is
common practice to prescribe antidepressants for patients presenting symptoms of anxiety and
depression when that is not always the most practical solution (Hyde, Calnan, Prior, Lewis,
Kessler, & Sharp, 2005). A study investigating the success of drug therapy alone versus drug
therapy combined with psychoanalytical therapy found that the combined treatment was far more
successful than drug therapy alone, and in fact psychotherapy alone was extremely effective
(Pampallona, Bollini, Tibaldi, Kupelnick, & Munizza, 2004).
Anti-depressant advertisements, like most commercial advertisements, are designed to
appeal to certain demographics and to play up the benefits of the product, while downplaying
negative aspects. According to Goldman and Montagne (1986), these kinds of advertising
techniques disrupt scientific discourse, certain types of social knowledge, and even discourage
professional debate regarding non-medicated treatment approaches to mental illnesses. Hersey‘s
(2004) exploratory study investigating how the portrayal of depression in pharmaceutical
advertisements has changed through the years since 1980 used content analytic and qualitative
methods to analyze advertisements. The researchers found that increased use of female models
dominated the advertisements through this time period, and that the advertisements portrayed an
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increased number of ―
recovered‖ patients. Commercials using these tactics were less likely to
focus on negative information, both in defining social interactions in the individuals portrayed,
and in the information given regarding treatment (Hersey, 2004).
A recent study (Frosch, Krueger, Hornik, Cronholm, & Bart, 2007) examined the makeup
of DTCA for prescription medications, including anti-depressant advertisements. A sample of
103 ads was coded for regularities such as symptoms, mechanism of the disease, causes or
prevalence of a condition, and subpopulations at risk. Then the ads were coded for how they
would appeal to consumers, including rational, positive emotional, negative emotional, humor,
fantasy, sex, and nostalgia appeals in their sample. Finally, the authors examined how the actors
portrayed the role of the medication advertised in their characters‘ lives. The authors noted that
while all of the advertisements included factual information about risks and side effects to meet
regulatory requirements, most of the ads limited the information to symptoms and the biological
nature of the disease or condition instead of focusing on the risks associated with the medication.
According to the article, only one-fourth of the sample examined presented a complete list of risk
factors for the specific medical condition and an even smaller eight percent of the ads included
specific information about the populations at risk for the conditions (Frosch, et.al, 2007).
The study also found that almost all the ads examined included positive emotional claims
regarding the use of the medication, and the majority of the negative emotional appeals made
typically showed the actor in a negative state prior to the use of the advertised medication,
followed by a positive appearance after the use of the medication, creating a sympathetic and
motivating presentation for consumers. More than half of the same advertisements included
information that claimed or implied that the characters in the advertisement regained control of
lost functions, abilities, and emotional connections after use of the medication, which creates an
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equally compelling appeal for consumers exposed to DTCA for medication, especially antidepressants (Frosch, et.al, 2007).
While supporters of DTCA for medication may claim that there is little harm done to the
consumer by the advertising, due to the increased link between suicide and anti-depressants,
particularly in minors, many anti-depressant commercials, such as the popular Zoloft
advertisements, have been removed from broadcast (Rockoff & Wang, 2008), and company
websites have been forced to include efficacy statistics, as well as information about clinical
trials (Graber & Weckman, 2003), suggesting that the FDA does not agree. In February of 2004,
House Representative Henry A. Waxman criticized the FDA for allowing DTCA for prescription
medication to be misleading, giving consumers a skewed view of the medications‘ benefits and
risks. The FDA responded by releasing new guidelines for DTCA, but many critics are still
unsatisfied, claiming that the guidelines do not have enough application for television
advertisements and mainly focus on print and product labeling information, and that the material
is too complicated and loaded with technical jargon to be decipherable to anyone but a physician
(Young, 2004).
There are also examples of DTCA for prescription drugs being not only misleading but
false, including television commercials. For instance, Pfizer ran a series of commercials in 2007
advertising the cholesterol medication Lipitor with spokesman Dr. Robert Jarvik, who was touted
as the inventor of the artificial heart and was portrayed as an accomplished rower. Investigations
into claims made by the medical community revealed that not only was a body double used in
the rowing scenes that made up much of the commercial, but Robert Jarvik was not the sole
creator of the artificial heart and was in fact not a licensed physician at the time (Wedekind,
2008). The president of Pfizer was compelled to admit that the misleading way in which Robert
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Jarvik was represented in the advertisements led to ―
misimpressions and distractions,‖ ultimately
harming consumer perceptions regarding cardiovascular disease and its treatments. In January of
2008, The House Committee on Energy and Commerce's Subcommittee on Oversight and
Investigations started an investigation into "false and misleading statements and the use of
celebrity endorsements of prescription medications in direct-to-consumer advertising,‖ which
found that Pfizer was not the only company responsible for misleading advertisements, despite
recent regulations released by the FDA. The committee acknowledged that some of the most
popular DTCA for prescription medications practiced deceptive tactics (Dingell, 2008).
A number of recent advertisements have not been for any specific anti-depressant drugs,
but have been generalized advertisements about depression from drug companies directing
viewers to websites with more information on treatment. Graber and Weckman (2003) examined
the websites of anti-depressants and their companies for a varied and thorough presentation of
both the benefits and the risks of anti-depressant treatment found that out of nine websites, three
contained anecdotal information designed to make the practice of drug treatment seem more
common to the potential customer. Only four of the websites mentioned other drug therapy as
treatment, and only one mentioned the trade names of other drugs. None of the websites
mentioned drug costs; only one had efficacy statistics for the drug. While all of the websites
mentioned at least one adverse effect, only one site had percentage rates for adverse effects, and
none of the sites listed all adverse effects found in clinical trials. Graber and Weckman
concluded that information about anti-depressants found on their own company websites is
faulty, incomplete, and makes it difficult for consumers to compare drugs and other methods of
treatment.
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There are few studies that deal directly with the attitudes of the population toward
depression. The incorporation of this measure should be essential in determining the prevalence
and seriousness of depressive disorders in the U.S.; the general lack of knowledge regarding
depression and its treatments adds to the dilemma (Goldney et al., 2001). Studies in this field are
limited. Most deal with the diagnosis and treatment of depression, not the general perception of
the disorder. One study measured mental health literacy, and found that only thirty-nine percent
of a community sample correctly labeled depression (Goldney et al., 2001). Though this study
did not examine the effect of advertisements on public opinion, it does give broad measure of
perception, and provides a basic idea of how poorly informed people are on the subject.
Supporters of pharmaceutical advertising argue that the advertisements are not meant to
mislead consumers, but to inform regarding disorders and the prescription drugs used to treat
them. Pharmaceutical companies claim that DTCA is meant to encourage consumers to talk to
their doctors about the drugs and is not meant to influence purchasing behavior (Holmer, 1999).
Supporters argue that DTCA can actually improve public health and knowledge about diseases
that are frequently misunderstood or misdiagnosed, and will encourage consumers to seek out
other sources of information, whether from friends, family, doctors, or even other popular media
(Royne & Myers, 2008). According to a review of current literature regarding DTCA, it was
suggested that proponents of DTCA claim that the increased availability of complex and
sometimes inaccessible information is a significant benefit for the general public, giving them
the opportunity to make informed decisions about their health care. Supporters also claim that
advertising of medications encourages consumers to take a more active role in personal health
and provides necessary information to help them seek medical attention for conditions that might
otherwise go unidentified and untreated (Royne & Myers, 2008). It is also acknowledged that

13
DTCA is not the only source of information on popular medications; while DTCA sometimes
provides a catalyst for consumers to seek information about a particular medication, many
consumers have existing knowledge regarding popular medications based on information from
family members, friends, or earlier discussions with physicians. DTCA supporters conclude that
while DTCA is an important informative tool for the general public, it is by no means the only
source of information (Royne & Myers, 2008).
Huh and Becker (2005) found that especially ―
older and less educated consumers benefit
from prescription drug advertising since they are more likely to be ready to communicate with
their doctors.‖ The research also suggested that women who view DTC prescription advertising
are more likely to seek out information independently and be able to communicate more
effectively with their doctors (Huh & Becker, 2005).
A study conducted by Limbu and Torres (2009) examined the difference in effectiveness
of DTC prescription advertising with consumers who were considered either low or high
involvement. Those with low involvement were considered to have less interest and concern in
an object or product before exposure to advertising, while those with high involvement displayed
higher levels of interest and concern in an object or product before exposure. The researchers
argued that consumers with high involvement were more likely to approach their doctors about
the prescription drug advertised than those with low involvement. Based on their findings,
Limbu and Torres suggested that persuasive DTCA is more likely to encourage high
involvement consumers to communicate with doctors about an advertised drug; the researchers
concluded that the advertising would mainly appeal to those who would already be susceptible to
persuasive advertising (Limbu & Torres, 2009).
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Herzenstein, Misra, and Posavac (2005) claimed that consumers‘ attitudes regarding DTC
prescription advertising were neither favorable nor unfavorable, but that attitudes were related to
whether consumers independently sought out further information about the drug, asked their
doctors about the drug, or were likely to seek out relevant information from a friend or local
pharmacist. Consumers who rely on interpersonal aid and mass media in discovering health
information tend to have more positive attitudes regarding DTCA (Lee, Salmon, & Paek, 2007).
Oncology Nurse Practitioners (ONPs) were surveyed regarding their opinions on DTC
prescription advertising. While they were found to have mixed opinions regarding the practice,
most did not believe that they were heavily influenced by relevant advertising with regard to
patients‘ prescriptions. The surveyed ONPs also suggested that patients who asked about specific
medications based on DTCA were generally interested in the veracity of the information
presented and it did not seem to have a significant effect on their requests for specific medication
(Viale & Yamamoto, 2004).
Depressive disorders are most common in adults, and one of the major populations of that
community is college students. As part of the population getting their general information on
depression from commercials and magazine articles, according to the APA, the number of
unreported cases of depression is growing. Abernathy and Adams-Price (2006) compared older
versus younger adults‘ ability to remember and comprehend drug information. They found that
younger adults had a greater increase in their knowledge of the drugs presented in the advertising
condition. For college students dealing with the extra stressors of college life, depression is a
common problem and they are likely to seek out treatment; however, many may be biased in
their attitudes toward the disease, as well as its treatment due to the increase in DTCA of antidepressants (Pilcher, 1998).
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The college age population is essentially important as it is a milestone growth into
adulthood from adolescence (Persi, 1997). For students faced with high stress, social behavior
expectancies, and absence from family, depression can be triggered by an already existing
tendency to the disorder (Pilcher, 1998). During college years, many young adults are
introduced to new developmental tasks and responsibilities, which are often linked to mental
distress (Apfel, 2003). One particular case study noted the difficulty experienced by teenagers
suffering from emotional disorders in making the transition to adulthood (Gilbody & Davis,
1999). A study conducted through the 2007 Annenberg National Health Communication survey
investigated the impact of exposure to DTCA for prescription anti-depressants and anti-anxiety
medications on public perception and opinion regarding treatment for youth experiencing
depression or anxiety. The survey was distributed to a sample group of adults who were exposed
to current DTCA for anti-depressants and found that those among the group who did not have
previously negative attitudes towards DTCA were more likely to prefer the medications
advertised in the treatment of youths with depression or anxiety, while those who had previously
expressed negative perceptions of DTCA were less likely to respond positively to the
medications advertised (Martinez & Lewis, 2009). Because of the delicate nature of mental
illnesses such as depression, it is imperative to be able to accurately identify depression and seek
appropriate treatment, which may or may not include a popularly advertised medication, for
which a general practitioner may or may not be sufficient (Gilbody & Davis, 1999).
The influence of advertising on college students is as prevalent as with the general adult
public. Depression has been an issue of growing concern for college students (Apfel, 2003). A
longitudinal study at a university counseling center found that the number of students seeking
help for depression doubled from 1988 to 2001 (Benton, Robertson, Tseng, Newton, & Benton,
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2003). In addition, anti-depressants have become the most popular form of treatment prescribed
despite availability of many other alternatives (Jureidini & Tonkin, 2006).
Students are more likely to confuse transitional and typical distress associated with age,
stress, and isolation with depression; the common phrase found in drug advertisements ―a
sk your
doctor if this [medication name] is right for you,‖ encourages students to seek out drug therapy
rather than attempt less aggressive methods (Kadison, 2005). Family and friends exposed to
these advertisements may also add to the impression of students experiencing depression by
suggesting that ―
symptoms‖ exhibited by students are indicators of a mental disorder (Kadison,
2005). Some students are also developing the view that antidepressant medication will maximize
school performance, neutralize anxiety, or provide a mood boost. While it is possible that
increased visibility and awareness of depression may reduce the public stigma attached to
common mental disorders, it also suggests that the advertisements are a ―
magic bullet‖ for young
adults‘ complex and varied problems (Kadison, 2005).
In fact, a study conducted at the University of Wyoming examined college students‘
perceptions of depression when given the typical explanation found in prevalent advertising that
depression is a chemical imbalance versus a more accurate biopsychosocial explanation. The
study found that students who accepted the chemical imbalance explanation were more likely to
view drug treatment more favorably than psychotherapy, while students who accepted the
biopsychosocial explanation were more inclined toward therapy and less favorable about drugs.
The findings suggest that commercials that use the chemical imbalance explanation are more
likely to influence consumers and college students in particular to view prescription drug
treatments as more effective than therapy, which is harmful to the overall view of depression and
its treatment (Deacon & Baird, 2009).
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In order to better understand college students‘ perception and use of widely advertised
prescription medications, one study surveyed over four-hundred students from three separate
institutions regarding their use of advertised medications, how much attention they paid to
advertisements, their level of communication with physicians regarding the medications, and
their perceptions of the conditions treated by the advertised medications (Burak & Damico,
2000). The researchers found that the majority of the students surveyed used at least one of the
advertised products they were questioned about and most students did not discuss alternative
pharmaceutical products with their doctors, nor did they discuss the conditions with their
doctors. As Burak and Damico claim, since young people, including college students, are more
likely to take more than the recommended dosage or take medication for purposes other than
intended, or even in combination with other drugs, there is concern that advertising, especially if
it is faulty or misleading might encourage students to seek out unnecessary medication or use
their prescriptions to adverse reactions. According to the article, young adults are more likely to
self-medicate and are generally less open with their physicians, making them particularly
susceptible to prevalent advertising that describes their perceived symptoms and treatment in one
commercial (Burak & Damico, 2000).
A study conducted to determine the effectiveness of anti-depressant advertising on
undergraduates in a university separated participants into two groups: a scientific study condition
and an advertisement condition. Based on the Beck Depression Inventory used by the
researchers, 40% of the female participants in the advertisement condition believed they were
experiencing depression after being exposed to the advertisement, as opposed to 6% in the
scientific study condition. The results suggest that female participants in the advertisement
condition were more likely to believe that they had depression, that depression required
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treatment with anti-depressants, and were likely to suggest anti-depressant treatment to family
and friends (Frankenberger, Frankenberger, Peden, Hunt, Raschick, Steller, & Peterson, 2004).
As with any disease, those suffering from depression need to be aware of symptoms and
treatment options. Recently, the increase in medication advertisement, as well as patient
demand, has begun to influence doctors‘ decisions (Schwenk, 2005). For a single episode of
depression, an average physician will prescribe anti-depressants for up to nine months without
requiring a psychological workup (Demytteneaere, Bruffarets, Albert, Mesters, Dewe,
Debruyckere, & Sangeleer, 2004). Since the 1980s it has become routine to prescribe such drugs
as a management of depression; however, the negative effects are beginning to show in longterm users (Nierenberg, 1999). It is crucial to correctly identify and treat depression, not only to
ensure attention from those actually suffering from a major depressive disorder, but also to
prevent any negative side effects or even suicide in those being treated unnecessarily.
There is a need to expand upon these studies in the realm of college students‘ perception
of depression (Frankenberger, et. al., 2004). It is not pertinent to this study to screen for
depression or discuss in depth the symptoms, but only to ascertain the general perceptions of the
disease. The influence of advertisements and incorrect information is also of interest; it is
important to see if such methods of communication are harmful to the general population‘s
perception of depressive disorders.
The following study was designed to determine how much of an effect, if any,
advertisements have on college students‘ perceptions of depression and anti-depressants. As
there is very little research on this subject pertaining to college students and young adults (Royne
& Myers, 2008), the researcher intends to investigate how DTCA affects beliefs and perceptions
on the effects of anti-depressants, the risks associated with them, and overall knowledge about
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depression after exposure to a manufactured broadcast advertisement. The researcher is
interested in determining whether the questionable material being presented in television DTCA
is not only influencing treatment preferences, but is also adding to the already confused
perceptions of depression, or if it is simply adding to the collective knowledge regarding
depression and its treatment.
For the purposes of this study, the following questions will be researched:
RQ1:Will sampled Marshall University students learn claims from an example of DTC
medication advertising?
RQ2:Will the advertisement have an effect on their perceptions of depression and its
treatment?
RQ3:Will misleading information buried in an advertisement influence students‘
responses regarding informational questions about depression and treatment?
RQ4: Based on Bandura‘s Social Learning Theory which states that individuals learn
behavior from models presented in a stimulating and accessible manner (Bandura, 1997),
will students learn faulty information from a constructed advertisement?
The researcher anticipates the effects of incorrect or misleading information presented in
commercial form will significantly alter participants‘ perceptions of depression and antidepressants, and will create a link between DTCA and specific ideas about medication.
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Chapter Three: Methods
The researcher conducted an exploratory study on the effects on Marshall University
students‘ perceptions of depression and treatment by creating two advertisement conditions and
maintaining a control group in a single exposure experiment.
Respondents
In order to provide a pool of participants of the correct age and interests, the participants
were drawn from both graduate and undergraduate Marshall University classes as a cross-section
of the university‘s population. The researcher sent requests to several professors in different
departments at Marshall University for the use of time during classes to conduct the study, and
with permission from cooperating instructors, the researcher was able to draw a convenience
sample of 90 participants, with 30 participants in each of the three test groups. There was no
incentive for participation; participants were recruited on a voluntary basis. Students in
psychology classes and psychology majors were excluded from the study in order to eliminate
possible bias; the researcher believed due to the psychology curriculum there was a possibility
for prior knowledge of depression and treatments that would alter participants‘ responses and
therefore render the results invalid. The participants were treated in accordance with the
American Psychological Association ethical guidelines, as well as Marshall University‘s
Institutional Review Board‘s requirements.
Apparatus
The researcher determined which anti-depressants were among the top-searched
medications on the Internet (Newell, 2008), the researcher viewed advertisements for each of the
medications including Effexor, Cymbalta, Lexapro, and Paxil, to analyze the common
components used in the DTCA. After visiting the websites for the medications, it was clear that
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the television commercials would be most representative of DTC prescription advertising, due to
the length of the ad and the visual aspect of video and music, which was not found on each
website. Each commercial was recorded from television and viewed four times. The researcher
determined a pattern to certain elements that could be reproduced for the purposes of the study:
first, the portrayal of actors in depressed or negative poses, usually with slow music and dim
lighting in the background; second, a basic description of depressive symptoms including the
loss of interest in activities, anxiety, suicidal thoughts, etc.; third, the commercials claimed that
depression is caused by a chemical imbalance; finally, the commercials gave a brief description
of the risks associated with the medication, and then showed the actors in a more positive setting,
recovering lost abilities or relationships, and played upbeat music with brighter lighting in the
background, in many cases, placing the actors in a bright outdoor setting.
Based on these common components, the researcher created two versions of a
commercial encouraging the general use of anti-depressants. The commercial followed the basic
format of the researched anti-depressant advertisements; since the advertisements reviewed were
between 30 seconds and 120 seconds, the manufactured commercial was one-minute long and
featured several different actors of both genders ranging from college-age to middle-age. The
commercial opened with basic information about depression similar to that in the reviewed
commercials and then shifted into information about anti-depressants and how they improve
depressive symptoms (see Figure 4.1). In the first half, the actors were shown experiencing a loss
of enjoyment of activities such as playing with a dog, frustration at work, marital difficulties, and
apathy; in congruence with the reviewed advertisements, the music was slow and the lighting
was dim. During this portion, the information about depression was revealed, including the
common assertion that depression is caused by a chemical imbalance. The advertisement then
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transitioned into the positive segment, portraying the actors enjoying activities again, smiling and
displaying happiness in relationships; the lighting was also brighter and most of the scenes were
shown out of doors with more upbeat music playing in the background, as was described in the
study that examined the negative and positive emotional appeals in DTC medication advertising
(Frosch, et.al, 2007).
Due to the arguable presence of misleading or false information in prevalent medication
advertising, such as the previously described example of Lipitor, and the concerns raised by the
government about misleading prescription DTCA and the FDA‘s slow response to addressing
inconsistencies and misleading information in DTC television advertisements (Young, 2004), the
researcher chose to create a version of the commercial with three inaccurate or misleading
statements regarding anti-depressants, their use, and possible side effects. The incorrect
statements were based on information in an article that investigated common misconceptions and
perceptions of depression and antidepressants. The article suggests that participants frequently
believed falsely that: 1. Anti-Depressants will not cause withdrawal symptoms when ceased
suddenly; 2. Depression causes suicide; 3. Depression can be diagnosed in one doctor‘s visit, and
treatment can be decided in the same visit (Hegerl, Althaus, & Stefanek, 2003). All of the
information used to construct the commercial as well as the survey was taken from articles on the
American Psychological Association (APA) website. The version of the commercial without
misleading statements was created in the same format, but omitted the incorrect or misleading
information. The commercials were presented to participants in two advertising conditions
during classes, with the permission of the instructors. Due to class sizes, which did not exceed 50
students in any case, the researcher was able to show the participants in each class either the
misleading commercial or the correct commercial using a DVD player on a laptop computer and

23
a projector, depending on the equipment available at the testing locations, which were in
Marshall University classrooms. In classrooms that did not have a projector available, the
students were asked to watch the DVD on the screen of the laptop.
The researcher developed a 15-question survey to measure the participants‘ perceptions
of depression and anti-depressants, to be taken following the viewing of the commercial. The
survey opened with brief demographic information to obtain the participants‘ age, major area of
study, and gender; the researcher used the information only to ensure that no surveys taken by
psychology majors were used. The questions were developed from statements frequently made in
the reviewed anti-depressant commercials, the manufactured commercial, and information from
the APA website. The survey was set up as a true/false condition; participants were presented
with a statement that they could either qualify as true or false based on their own perceptions.
Questions four (Anti-depressants will not cause withdrawal symptoms when ceased abruptly),
twelve (Depression causes suicide), and fifteen (Depression can be diagnosed in one doctor‘s
visit, and treatment can be decided in the same visit), corresponded directly to the false
statements in the commercial and were designed to be a direct measure for the accuracy of
participants‘ knowledge about depression and anti-depressants. Other questions were taken from
the correct information in the commercial, and the remaining questions were taken from current
scientific information, as found on the APA website. Each question was formulated to
reasonably simulate information that might be found in actual DTCA without being a direct
quotation in order to ensure that the participants were only responding to the researcher‘s
manufactured commercial.
Procedure
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There were three test groups in the experiment: Group 1, an experimental group that
viewed the commercial with the false statements and then completed the survey directly after a
single exposure to the advertisement; experimental Group 2 viewed the version of the
commercial without the false statements and then completed the survey directly after a single
exposure to the advertisement; the control group (Group 3) completed the survey without
viewing either commercial.
Commercial w/out

Commercial with

misleading

misleading

information viewed

information viewed

Group 1

X

Survey Taken

X

(Experimental)
Group 2

X

X

(Experimental)
Group 3

X

(Control)

The participating classes were randomly assigned to one of the experimental groups or
the control group ahead of time.
Respondents were not informed beforehand that the commercial did or did not contain
misleading statements. Respondents viewed the commercial as it played on the projected screen
or the laptop screen. When the commercial ended, the lights were brought back up and the
respondents completed the survey following instructions to answer the questions honestly and in
accordance with their beliefs about the material presented. When the groups completed the
surveys, the researcher passed out the debriefing form (see figure 1.3), and thanked them and the
instructor for their time. Respondents in the test group were informed during debriefing that
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there had been false statements in the advertisement and were told what the false statements
were. The same procedure was followed with respondents in experimental Group 2.
The control group (Group 3) also signed consent forms and completed the questionnaire.
The group was debriefed, but was not exposed to any advertising. The control group helped to
ensure that differences in the responses of the experimental groups could be attributed to
information presented in the advertising condition, and did not come from prior or outside
knowledge.
Following the completion of the experiment, all participants were debriefed according to
APA and Marshall University IRB standards.
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Chapter Four: Results
The results are as follows:
Question 1: Depression is a mental disorder.
SUMMARY
F-ratio
Groups
Count Variance
Group 3
30 0.152116
Group 2
30 0.21164
Group 1
30 0.126984

0.946092

Question 2: Depression has genetic traits.
SUMMARY
F-ratio
Groups
Count Variance
Group 3
30 0.22619
Group 2
30 0.152116
Group 1
30 0.238095

1.216738

Question 3: Women are more likely to suffer from a depressive disorder.
SUMMARY
F-ratio
Groups
Count Variance
Group 3
30 0.189655
Group 2
30 0.169951
Group 1
30 0.169951

0.065116

Question 4: Antidepressants will not cause withdrawal symptoms when ceased.
(Test Question)
SUMMARY
F-ratio
Groups
Count Variance
Group 3
30 0.096059
Group 2
30 0.169951
Group 1
30 0.206897

1.385417

Question 5: Someone suffering from Depression is likely to be irritable and aggressive.
SUMMARY
F-ratio
Groups
Count Variance
Group 3
30 0.169951
Group 2
30 0.147783
Group 1
30 0.169951

0.070707
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Question 6: Depression is a disease.
SUMMARY
F-ratio
Groups
Count Variance
Group 3
30 0.258621
Group 2
30 0.251232
Group 1
30 0.258621

0.179487

Question 7: Depression is caused by a chemical imbalance in the brain.
SUMMARY
F-ratio
Groups
Count Variance
Group 3
30 0.066502
Group 2
30 0.066502
Group 1
30 0.096059

0.150538

Question 8: Antidepressants are non-habit forming.
SUMMARY
F-ratio
Groups
Count Variance
Group 3
30 0.034483
Group 2
30 0.251232
Group 1
30 0.096059

9.303226

Question 9: Depression can be a chronic problem.
SUMMARY
F-ratio
Groups
Count Variance
Group 3
30 0.034483
Group 2
30 0.096059
Group 1
30 0.034483

0.835821

Question 10: Depression can have physical symptoms, such as headaches, digestive disorders,
and chronic pain.
SUMMARY
F-ratio
Groups
Count Variance
Group 3
30 0.034483
Group 2
30 0.066502
Group 1
30 0.096059

0.525
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Question 11: People suffering from Depression tend to suffer from a sleeping disorder, such as
hypersomnia or insomnia.
SUMMARY
F-ratio
Groups
Count Variance
Group 3
30 0.096059
Group 2
30 0.096059
Group 1
30 0.066502

0.133333

Question 12: Depression causes suicide.
(Test Question)
SUMMARY
Groups

F-ratio
Count

3.635659

Variance

Group 3

30 0.206897

Group 2

30 0.169951

Group 1

30 0.258621

Question 13: Antidepressants can have physical side-effects.
SUMMARY
F-ratio
Groups
Count Variance
Group 3
30 0.096059
Group 2
30
0
Group 1
30 0.066502

1.484848

Question 14: Depression is a common problem; most people will experience or come in contact
with depression at some point during their lives.
SUMMARY
F-ratio
Groups
Count Variance
Group 3
30 0.147783
Group 2
30 0.123153
Group 1
30 0.123153

0.0875

Question 15: Depression can be diagnosed in one doctor‘s visit, and treatment can be decided in
the same visit.
(Test Question)
SUMMARY
Groups
Group 3
Group 2
Group 1

F-ratio
Count Variance
30 0.189655
30 0.23399
30 0.169951

0.755187
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Based on a 0.05 level of significance, the advertising condition did not have a significant
effect overall. The results of an Analysis of Variance (ANOVA) performed on correct responses
to question twelve, the second of the false information questions, showed a significant link
between the performance of the false advertising condition and the control group with a
significance level of 0.03. The responses to the other questions taken from the false statements
in the advertisement did not demonstrate a significant link.
There were four other questions that directly corresponded to truthful information in the
commercial; question three, question seven, question eight, and question fourteen. There was no
significant difference between the test group responses in any of the questions except for
question eight (Antidepressants are non-habit forming). The responses in both advertising
conditions differed significantly from the survey condition with a level of 0.0002. The responses,
however, were the opposite of the information presented in the commercial, displaying a
perception that antidepressants are habit-forming, which, according to the FDA (2007), is not
correct. There does not appear to be any concrete explanation for the results. Overall, the results
did not reflect the researcher‘s anticipation that the advertising condition would have a
significant effect on participants‘ responses. The two instances of significant difference are likely
not related to the advertising condition, but are due to extraneous factors.
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Chapter Five: Discussion
The results of the current study do not demonstrate a significant link between the
advertisement conditions and surveyed Marshall University students‘ perceptions of depression
and anti-depressants. Accuracy for questions four and fifteen were not significantly lower for
Group 1 than for the control group, which suggests that the advertisement did not affect the
participants‘ responses. For question twelve (depression causes suicide), accuracy did differ
significantly with a 0.03 level of significance; however, because this was the only question in
which there was a significant difference among the three test groups, it may be inferred that there
were other variables contributing to the results, and the responses were not solely based on the
information presented in the advertisement condition.
Overall, the results did not support the expectation that the advertising condition would
significantly alter the perceptions of participants regarding depression and its treatment. The
sampled Marshall University students were not influenced by the example provided of DTC
medication advertising, and it did not appear to have any significant effect on their perceptions of
depression and its treatment. The misleading information was correctly identified as false by the
respondents, which suggests that the respondents did not base their perceptions solely on the
advertisement, but were influenced by outside sources or prior knowledge. In this case, the
participants did not model behavior based on the advertisement, which also supports the
possibility that they had outside information on the subject presented.

As displayed in Figure 2.1., the results for question twelve (Depression causes suicide)
show that it is possible for anti-depressant advertisements with incorrect information to influence
participants‘ perceptions of depression and anti-depressants, or that there is a general perception
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that depression causes suicide. It is also possible that the wording of the question or information
in the commercial was misinterpreted by the respondents since none of the other misleading
statements appeared to influence responses significantly. The correct responses to the questions
corresponding to the other incorrect statements suggests that while some respondents may be
influenced to some degree by advertisements, they are also being influenced by information from
other undetermined sources. This conclusion is supported by the results for question eight
(Antidepressants are non-habit forming), which directly corresponded to correct information in
the advertisement; however the participants in the advertising conditions overwhelmingly
disagreed with the information. While the researcher can offer no definite explanation for the
results, it may be inferred that the participants had outside information or prior knowledge that
encouraged them to contradict the factual statement in the commercial.
The results of this study neither support nor contradict existing research that suggests
advertising, particularly DTCA, can have a significant effect on viewers, and that advertisers
should exercise caution in their selection of information for inclusion or exclusion in their
advertising (Graber & Weckman, 2003). A recent study argues that both ―
proponents and
opponents‖ of DTCA of prescription drugs assume that the ads increase prescriptions and
awareness of diseases and treatments (Holmes, 2008). A study conducted by Michael Law of
Harvard Medical School in Boston showed DTCA from the U.S. to viewers in Canada, where
DTCA is prohibited. The study found that only one of three medications advertised saw an
increase in prescription rate, and the effects only lasted for a few months. These findings suggest
there may be a relationship between DTCA and perceptions of depression, but there are other
sources of information that may contribute to the public‘s attitude.
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The researcher had anticipated that the misleading information in the advertisement
presented to Group 1 would significantly alter participants‘ perceptions of depression and
antidepressants, and would demonstrate a relationship between DTCA and specific ideas about
medication. The results of this study did not support the expected outcome, but several
unexplained results, including the significant link between the advertising condition and
participants‘ responses to question twelve (Depression causes suicide) and the participants‘
disagreement with correct information in question eight (Antidepressants are non-habit forming)
suggest that further research might generate different results.
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Chapter Six: Limitations and Recommendations
As there is very little existing literature dealing specifically with the views and
perceptions of college students and young adults regarding depression and anti-depressants and
how they are affected by direct-to-consumer advertising (Royne & Myers, 2007), this study
could be replicated in other university situations, as well as in adult groups. If the study were to
be investigated further, different media with the false information could be used, including a
manufactured print ad and several different advertisements. This study used a single exposure in
the advertising conditions; a future replication would benefit from having multiple exposures
over a period of time for greater likelihood of retention. A larger sample would be more
effective, such as from several different universities in the region, or at least a wider selection of
students from the university chosen.
Also, the use of focus groups could be a more effective means of measuring the influence
of advertisements; having the participants in a more controlled environment with multiple
exposures to varying types of advertising conditions could also affect the results differently. The
testing sites for this study were Marshall University classrooms with large groups of participants;
a more intimate setting with groups of no more than fifteen might be more effective and provide
fewer distractions for participants. Also, in future research, the survey should include questions
about where participants believe they obtain most of their existing knowledge about depression
in order to determine what outside sources might be affecting their responses in the advertising
conditions.
As a preliminary review before conducting the experiment, a future investigation might
wish to survey the sample group regarding general information readily available about the
subject matter before constructing the manufactured advertisement and survey in order to prevent
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cross-contamination from outside sources. A future investigation into the acceptance of both
correct and incorrect information in advertising may also provide insight into how the
information is processed and perceived by the general public.
When researching popular commercials for patterns in DTCA, a future investigation
should employ a panel of at least three members in determining the common elements. For the
purposes of this study, the researcher was the only individual identifying patterns, and a future
study would benefit from multiple viewers in order to identify the optimum patterns and
elements; it is a limitation of this study that the researcher was the sole determinant.
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Figure 1.1

Anonymous Survey Consent
You are invited to participate in a research project entitled The Effects of Anti-Depressant
Advertising on the Perception of Depression in College Students designed to analyze the effects,
if any, of anti-depressant advertising on college students‘ perceptions of depression and its
treatment. The study is being conducted by Dr. Chris Swindell –Primary Investigator and
Deirdre Robertson – Co-Investigator from Marshall University. This research is being
conducted as part of the thesis requirements for Deirdre Robertson.
This survey is comprised of 15 questions regarding depression and anti-depressants, and 3
questions about particpants‘ overall knowledge of depression. The survey will take 5-10 minutes
to complete. Your replies will be anonymous, so do not put your name anywhere on the form.
There are no known risks involved with this study. Participation is completely voluntary and
there will be no penalty or loss of benefits if you choose to not participate in this research study
or withdraw. If you choose not to participate you may either return the blank survey or you may
discard it. You may choose to not answer any question by simply leaving it blank. Returning the
survey to the researcher indicates your consent for use of the answers you supply. If you have
any questions about the study you may contact Dr. Chris Swindell in the Communications
Building of Marshall University or Deirdre Robertson at (304) 733-4003.
If you have any questions concerning your rights as a research participant you may contact the
Marshall University Office of Research Integrity at (304) 696-4303.
By completing this survey and returning it you are also confirming that you are 18 years of age
or older.
Please keep this page for your records.
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Informed Consent Form
I agree to participate in the observational research conducted by Deirdre Robertson. I understand
that the proposed research has been reviewed by the Marshall University Institutional Review
Board and that to the best of their ability they have determined that the observations involve no
invasion of my rights of privacy, nor do they incorporate any procedure or requirements which
may be found morally or ethically objectionable. If, however, at any time I wish to terminate my
participation in this study I have the right to do so without penalty.
If not 18 years of age, please do not participate in this study.
If you have any questions about this study, you should feel free to ask them now or anytime
throughout the study by contacting Deirdre Robertson

You may report any objections to the study, either orally or in writing, to any of the following
people:
Dr. Chris Swindell
Supervisor
Department of Journalism and
Mass Communication
Communications Building

Deirdre E. Robertson
Primary Investigator
414 Garden Lane
Huntington, WV 25705
(304) 733-4003

Purpose of the Study: The researcher intends to measure the perceptions of Marshall University
students regarding depression and its treatment, and explore any link between said perceptions
and popular advertisements.
I understand that to maintain anonymity in analysis and reporting, no participant‘s name will be
saved. All experimental data will be separated from the signed consent form to preserve
confidentiality. Only members of the research group will have access to the data from this
experiment.
I understand that in signing this consent form, I give Deirdre Robertson and associates on this
project permission to present this work, both in written and oral form, without further permission
from me.
Name:_____________________________
Date:______/______/______

Signature:__________________________
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Debriefing Form
This form is to inform participants about the true purpose of the study. To avoid bias, the
researcher withheld this information initially. The commercial which was presented was created
by the researcher in order to determine how strong an effect advertisements have on college
students‘ perceptions of depression. The researcher included several incorrect statements in the
commercial in order to determine whether incorrect information could influence said
perceptions. The incorrect statements were as follows:
- Anti-depressant medications will not cause withdrawal symptoms when ceased suddenly.
- Depression causes suicide.
- Depression can be diagnosed in one doctor‘s visit, and treatment can be decided in the
same visit.
The study is being conducted in order to determine whether there is a link between
advertisements for anti-depressants (through television) and incorrect perceptions of depression
and treatment. The researcher is also analyzing actual anti-depressant advertisements to
determine whether or not incorrect information is being included.
If you have any further questions, would like to know the results
of the study when it is completed, or would like your data to be
excluded from the study, please contact the following:
Deirdre E. Robertson
Primary Investigator
414 Garden Lane
Huntington, WV 25705
(304) 733-4003
Thank you for your participation.
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The chart above demonstrates that there were no significant differences in accuracy for any
question but question twelve (Depression causes suicide), in which accuracy did differ with a
0.03 level of significance. The results for question eight (Antidepressants are non-habit forming)
demonstrate that the respondents disagreed significantly with the correct statement provided in
the commercial corresponding with that question; the researcher can only infer that the
participants had outside knowledge that contradicted with the question. The overall inference is
that there is no direct link between the advertisement conditions and participants‘ responses.
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Questionnaire:
The following is to determine demographics; please answer honestly
Age:
Major:
Gender: Male or Female

The following survey is meant to measure attitudes and perceptions of depression and its treatment.
Please answer the questions as honestly as possible in order to achieve the best results. Please follow the
directions carefully.

Please circle T for statements you consider true, or circle F for the statements you consider
false.
1. Depression is a mental disorder.
T

F

2. Depression has genetic traits.
T

F

3. Women are more likely to suffer from a depressive disorder.
T

F

4. Anti-Depressants will not cause withdrawal symptoms when ceased abruptly.
T

F

5. Someone suffering from Depression is likely to be irritable and aggressive.
T

F

6. Depression is a disease.
T

F
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7. Depression is caused by a chemical imbalance in the brain.
T

F

8. Anti-depressants are non-habit forming.
T

F

9. Depression can be a chronic problem.
T

F

10. Depression can have physical symptoms, such as headaches, digestive disorders, and
chronic pain.
T

F

11. People suffering from Depression tend to suffer from a sleeping disorder, such as
hypersomnia or insomnia.
T

F

12. Depression causes suicide.
T

F

13. Anti-depressants can have physical side-effects.
T

F

14. Depression is a common problem; most people will experience or come in contact with
depression at some point during their lives.
T

F

15. Depression can be diagnosed in one doctor‘s visit, and treatment can be decided in the same
visit.
T

F
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